A Novel Adhesive Based Skin Closure System.
Developed by Resivant Medical
Discovered at the University of Akron
School of Polymer Sciences
Resivant Medical holds an exclusive license from the University of Akron
Research Foundation and has additional patents pending. The proprietary Cutiva™ adhesive platform promises a new and advanced means of safe, simple and secure skin closure.
*Cutiva™ products are not yet FDA approved for human use.
Innovative Adhesive Applicator
Cutiva™ Topical Skin Closure
An adhesive should be easy to use and simple to apply. The Cutiva™ novel applicator is ergonomically designed for single hand use and controllable dispensing, as needed.
Resivant’s pre-design studies indicate improved cosmetic results when compared to sutures, and enhanced mechanical performance compared to other adhesives. Safety was apparent from both histology and visual observation of skin reactions. Cutiva™ is not FDA-cleared for human use.
Cutiva™ PLUS Topical Skin
Cutiva™ PLUS Skin Closure System is
designed to extend the Cutiva™ platform into
an adhesive with an added surgical mesh. The
mesh is intended to provide added strength in
lieu of sutures and would be positioned on the
skin while the adhesive is then applied onto
the mesh. This forms a reinforced, strong,
flexible, durable and soft barrier to better
protect the surgical site while healing occurs.
*Cutiva™ products are not yet FDA approved
for human use.